Showing 15 posts of 111 posts found.


FDA halts allergy drug approval process due to government shutdown

January 15, 2019
Research and Development Aimmune, FDA, Trump, governmetn, shutdown

California-based pharma firm, Aimunne Therapeutics has been notified that due to the government shutdown, the US Food and Drug Administration …


Sanders calls on Trump to support drug pricing bill

January 11, 2019
Medical Communications Bernie Sanders, Trump, access, pharma, pricing

Senator Bernie Sanders has called on President Donald Trump to support new legislation aimed at cutting prices on prescription drugs. …


Top Ten most popular articles on this week!

December 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …


Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV

December 10, 2018
Sales and Marketing HIV, Trump, US government, feotal tissue, mice, research

The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, …

Pfizer to resume price hiking in 2019; 41 drugs set to increase

November 20, 2018
Manufacturing and Production, Sales and Marketing Pfizer, Trump, pharma, price hikes, price hiking, pricing

American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its …


Pharma stocks soar after US midterm elections

November 8, 2018
Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market

Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …

Former Celgene CEO Bob Hugin loses in US midterm elections

November 7, 2018
Research and Development Bob Hugin, Celgene, Trump, midterms, republican, us politics

Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters …


Top Ten most popular articles on this week!

November 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

Novo Nordisk cuts 1300 jobs in the midst of Trump’s pricing pressures and depreciation of US dollar

November 2, 2018
Medical Communications Jobs, Novo Nordisk, Trump, pressure, pricing, revenue

Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision …


President Trump unveils new plans to bring US drug prices in line with the rest of the world

October 26, 2018
Medical Communications, Sales and Marketing Drug pricing, Trump, US, pharma

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …

FDA generics approvals up 90% compared to 2014

October 25, 2018
Sales and Marketing FDA, Trump, generics, pharma

Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic …


Top Ten most popular articles on this week

October 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …


Trump administration propose ruling requiring price transparency on TV ads

October 16, 2018
Manufacturing and Production Alex Azar, Drug pricing, Trump, access, adverts

US Health and Human Services Secretary Alex Azar, has announced a proposal which would require pharma firms to include the …


New US trade policy may limit foreign investment into biotechs

October 11, 2018
Research and Development CIFUS, Trump, america, biotech, capital, foreign investment

The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and …

Latest content